This turns Google DeepMind’s science stack into a named national partnership instead of another generic AI pledge. The plan starts with a Seoul AI Campus, work with SNU and KAIST, and an AlphaFold base already used by more than 85,000 researchers in Korea.
Google DeepMind said on X that it is expanding AlphaFold Database with millions of AI-predicted protein complex structures in collaboration with EMBL-EBI, NVIDIA, and Seoul National University. The release pushes AlphaFold beyond single-protein structure prediction toward a broader public resource for studying how proteins interact.
Isomorphic Labs, the DeepMind spin-off focused on AI-driven drug discovery, has unveiled a new AI that scientists are calling a generational leap comparable to AlphaFold.
Google DeepMind spin-off Isomorphic Labs published a technical report on IsoDDE, a proprietary drug discovery AI that scientists are comparing to a hypothetical AlphaFold 4. The model excels at predicting protein-drug binding and has secured billion-dollar deals with J&J, Eli Lilly, and Novartis.
Google DeepMind spinoff Isomorphic Labs revealed IsoDDE, an AI drug design engine that more than doubles AlphaFold 3's accuracy. It reduces drug discovery timelines from years to months, transforming pharmaceutical R&D.